Cited by 131AI in cancer detectionRadiomics and Machine Learning in Medical ImagingCancer Immunotherapy and Biomarkers

Multi-Field-of-View Deep Learning Model Predicts Nonsmall Cell Lung Cancer Programmed Death-Ligand 1 Status from Whole-Slide Hematoxylin and Eosin Images

Open access
Sha, Lingdao, Osinski, Boleslaw L., Ho, Irvin Y., Tan, Timothy L., Willis, Caleb, Weiss, Hannah, Beaubier, Nike, Mahon, Brett M. +2 more·2019·Journal of Pathology Informatics

Abstract

Background: Tumor programmed death-ligand 1 (PD-L1) status is useful in determining which patients may benefit from programmed death-1 (PD-1)/PD-L1 inhibitors. However, little is known about the association between PD-L1 status and tumor histopathological patterns. Using deep learning, we predicted PD-L1 status from hematoxylin and eosin (H and E) whole-slide images (WSIs) of nonsmall cell lung cancer (NSCLC) tumor samples. Materials and Methods: One hundred and thirty NSCLC patients were randomly assigned to training (n = 48) or test (n = 82) cohorts. A pair of H and E and PD-L1-immunostained WSIs was obtained for each patient. A pathologist annotated PD-L1 positive and negative tumor regions on the training samples using immunostained WSIs for reference. From the H and E WSIs, over 145,000 training tiles were generated and used to train a multi-field-of-view deep learning model with a residual neural network backbone. Results: The trained model accurately predicted tumor PD-L1 status on the held-out test cohort of H and E WSIs, which was balanced for PD-L1 status (area under the receiver operating characteristic curve [AUC] =0.80, P<< 0.01). The model remained effective over a range of PD-L1 cutoff thresholds (AUC = 0.67-0.81, P ≤ 0.01) and when different proportions of the labels were randomly shuffled to simulate interpathologist disagreement (AUC = 0.63-0.77, P ≤ 0.03). Conclusions: A robust deep learning model was developed to predict tumor PD-L1 status from H and E WSIs in NSCLC. These results suggest that PD-L1 expression is correlated with the morphological features of the tumor microenvironment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4103/jpi.jpi_24_19

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Numerous deep learning studies for predicting ICI responses in NSCLC from H&E images are primarily focused on refining PD-L1 quantification.

    “While numerous deep learning studies have emerged for predicting ICI responses in NSCLC from H&E images, they are primarily focused on refining PD-L1 quantification56–58.”

    From Predicting the tumor microenvironment composition and immunotherapy response in non-small cell lung cancer from digital histopathology images (2024) · cites this paper as [57]

    The Conclusions describe a deep learning model that predicts PD-L1 status from H&E whole-slide images in NSCLC, supporting this paper as an example of work focused on PD-L1 assessment. It does not report direct prediction of ICI response or refinement of PD-L1 quantification; the Discussion describes response prediction as a possible future study. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Numerous studies have demonstrated potential for AI to predict immunotherapy biomarkers from H&E images of NSCLC, including TMB, PD-L1 expression, and TILs.

    “Numerous studies have demonstrated the potential for using AI to predict immunotherapy biomarkers from H&E images of patients with NSCLC, including tumor mutation burden (TMB; ref. 76), PD-L1 expression (105), and TILs (106, 107).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [33]Schaumberg AJ Rubin MA Fuchs TJ H and E-stained Whole Slide Image Deep Learning Predicts SPOP Mutation State in Prostate Cancer bioRxiv 2018 064279

Cited by

Sorted by citations

Authors
Sha, L., Osinski, B. L., Ho, I. Y., Tan, T. L., Willis, C., Weiss, H., Beaubier, N., Mahon, B. M., Taxter, T. J., & Yip, S. S. F.
Affiliations
  • Tempus Labs (United States) (US)
  • Northwestern University (US)
Corresponding author
Yip, Stephen S. F
Venue
Journal of Pathology Informatics
Publisher
Elsevier BV
Published
2019-01
Volume
10
Issue
1
Pages
24
ISSN
2153-3539 (ISSN-L)
OpenAlex
W2963652908
Cited by
130
References
48
Citations by year
2026: 9 · 2025: 21 · 2024: 25 · 2023: 13 · 2022: 27 · 2021: 16 · 2020: 18 · 2019: 1
FWCI
7.30
Type
journal article
Language
en
Open access
Locations
  • Journal of Pathology Informatics (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
non-small cell lung cancer, PD-L1 expression, whole slide images, H&E staining, deep learning, ResNet, tumor microenvironment, immunohistochemistry, PD-1/PD-L1 inhibitors, histopathological features

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review